Tech Center 1600 • Art Units: 1629 1671 1685
This examiner grants 37% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17839353 | SPECIALIST SIGNAL PROFILERS FOR BASE CALLING | Non-Final OA | Illumina, Inc. |
| 17563934 | MACHINE LEARNING MODEL FOR RECALIBRATING NUCLEOTIDE BASE CALLS CORRESPONDING TO TARGET VARIANTS | Final Rejection | Illumina, Inc. |
| 17219338 | DETERMINING TUMOR FRACTION FOR A SAMPLE BASED ON METHYL BINDING DOMAIN CALIBRATION DATA | Non-Final OA | GUARDANT HEALTH, INC. |
| 16817489 | Systems and Methods for Determining Molecular Structures with Molecular-Orbital-Based Features | Final Rejection | California Institute of Technology |
| 17876324 | FEATURE AMOUNT SELECTION METHOD, FEATURE AMOUNT SELECTION PROGRAM, MULTI-CLASS CLASSIFICATION METHOD, MULTI-CLASS CLASSIFICATION PROGRAM, FEATURE AMOUNT SELECTION DEVICE, MULTI-CLASS CLASSIFICATION DEVICE, AND FEATURE AMOUNT SET | Non-Final OA | FUJIFILM Corporation |
| 17095562 | METHODS AND SYSTEMS FOR IDENTIFYING, CLASSIFYING, AND/OR RANKING GENETIC SEQUENCES | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 16643094 | Physical Property Prediction Method and Physical Property Prediction System | Non-Final OA | Semiconductor Energy Laboratory Co., Ltd. |
| 17548084 | Systems and Methods for Homogenization of Disparate Datasets | Non-Final OA | Tempus AI, Inc. |
| 17616740 | DETERMINING CAUSES OF DISEASES SUCH AS CANCER, USING MACHINE LEARNING ANALYSIS OF GENETIC DATA | Final Rejection | The Johns Hopkins University |
| 18344471 | SENSOR CALIBRATION USING SIMULATED SENSOR MEASUREMENTS | Non-Final OA | MEDTRONIC MINIMED, INC. |
| 17880635 | VIRTUALLY TESTING FORCE PLACED ON A TOOTH | Non-Final OA | Align Technology, Inc. |
| 17252205 | METHODS AND SYSTEMS FOR CALLING PLOIDY STATES USING A NEURAL NETWORK | Non-Final OA | Natera, Inc. |
| 17784631 | CONTROL OF A THERAPEUTIC DELIVERY SYSTEM | Non-Final OA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 17237591 | Machine Learning Derived Multimorbidity Risk Scores for Generalizable Patient Populations | Non-Final OA | Elevance Health, Inc. |
| 17909152 | PREDICTIVE TEST FOR WHETHER A PATIENT WILL BENEFIT FROM PHARMACOGENOMICS TESTING | Non-Final OA | SANFORD HEALTH |
| 16538475 | DESIGN OF MOLECULES | Final Rejection | Recursion Pharmaceuticals Inc. |
| 17020432 | APPARATUS, SYSTEMS AND METHODS FOR DIAGNOSING PARKINSONS DISEASE FROM ELECTROENCEPHALOGRAPHY DATA | Final Rejection | University of Iowa Research Foundation |
| 16976808 | GENE MUTATION ASSESSMENT DEVICE, ASSESSMENT METHOD, PROGRAM, AND STORAGE MEDIUM | Final Rejection | OSAKA UNIVERSITY |
| 17221003 | GENE TO TRANSCRIPTOME ASSOCIATION PLATFORM FOR DRUG TARGET IDENTIFICATION | Final Rejection | University of South Carolina |
| 16750475 | PREDICTIVE DATA ANALYSIS USING CUSTOM-PARAMETERIZED DIMENSIONALITY REDUCTION | Final Rejection | Optum Services (Ireland) Limited |
| 17719321 | METHODS AND SYSTEMS FOR ENGINEERING BIOMOLECULES | Non-Final OA | Codexis, Inc. |
| 17144021 | BITERMINAL DNA FRAGMENT TYPES IN CELL-FREE SAMPLES AND USES THEREOF | Non-Final OA | GRAIL, Inc. |
| 17047676 | SYSTEMS AND METHODS FOR DETERMINING TUMOR FRACTION IN CELL-FREE NUCLEIC ACID | Non-Final OA | GRAIL, Inc. |
| 16936901 | SYSTEMS AND METHODS FOR DETERMINING TUMOR FRACTION | Non-Final OA | GRAIL, Inc. |
| 17770191 | METHOD AND SYSTEM FOR EVALUATING OPTIMIZED CONCENTRATION TRAJECTORIES FOR DRUG ADMINISTRATION | Non-Final OA | BERLINER INSTITUT FUER GESUNDHEITSFORSCHUNG ZENTRUM DIGITALE GESUNDHEIT |
| 17501498 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | Final Rejection | GBS Global BioPharma, Inc. |
| 17006360 | PATHOGENICITY SCORING SYSTEM FOR HUMAN CLINICAL GENETICS | Non-Final OA | Athena Diagnostics, Inc. |
| 16705783 | DETERMINATION OF CANCER TYPE IN A SUBJECT BY PROBABILISTIC MODELING OF CIRCULATING NUCLEIC ACID FRAGMENT ENDPOINTS | Non-Final OA | BELLWETHER BIO, INC. |
| 15418363 | SELF-IMPROVING METHOD OF USING ONLINE COMMUNITIES TO PREDICT HEALTH-RELATED OUTCOMES | Final Rejection | PatientsLikeMe LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy